LOS ANGELES: Great Lakes NeuroTechnologies, which makes mobile software and wearable devices for monitoring symptoms of Parkinson’s disease, has released a new clinical version of its technology that supports continuous monitoring.
Kinesia 360 is still a clinician-facing tool; it does not appear to be the direct-to-consumer offering which the company promised last April when it received a $1.5 million NIH grant…